Azithromycin Price Trend and Forecast

Azithromycin Regional Price Overview

Get the latest insights on price movement and trend analysis of Azithromycin in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Azithromycin Price Trend For the Q3 of 2024

Asia

The azithromycin market in the Asian region demonstrated a fluctuating pattern during the said period. Initially, the market maintained stable prices with a gradual upward movement due to consistent exports. The supply situation remained balanced, though logistics challenges and elevated freight charges contributed to increased operational costs.
 

Azithromycin Price Chart

Please Login or Subscribe to Access the Azithromycin Price Chart Data
 

Suppliers successfully passed these additional expenses to consumers due to the positive market sentiment. However, prices began declining towards the quarter's end as manufacturers focused on destocking activities, leading to increased market availability. Simultaneously, the terminal demand weakened, further contributing to the softening azithromycin prices in the final weeks of the quarter.

Europe

Azithromycin prices in Europe exhibited an oscillating trajectory throughout Q3’24. The market initially experienced upward momentum, supported by steady pharmaceutical sector demand and improved consumer sentiment due to easing inflation rates. Despite high logistics costs providing some upward pressure, the market witnessed a significant shift in dynamics towards the latter part of the quarter. The prices registered a downturn as demand fundamentals weakened considerably, prompting suppliers to adjust their pricing strategies.

North America

The US domestic market exhibited a mixed pricing trend during Q3’24. The period began with firm prices supported by positive consumer sentiment and supply chain constraints. Logistical challenges, including port congestion and vessel rerouting, created supply tightness that bolstered prices. However, the market momentum shifted as the quarter progressed, with prices declining due to weakening demand fundamentals and growing economic uncertainties.

Analyst Insight

According to Procurement Resource, Azithromycin prices are expected to maintain a somewhat similar trajectory; further price corrections depend on demand recovery and logistics situation improvement.
 

Azithromycin Price Trend for the Q2 of 2024

Asia

India saw a slight price drop for azithromycin and other high-demand medicines. Throughout the three months, azithromycin prices in India were confined and consolidated; however, the government tried to relax the prices of some commonly used medicines for common consumers.

The government lowered the prices of 41 commonly used medicines and six specific treatments for common health issues. Medications like hydrochlorothiazide tablets, antacid gel, atorvastatin, clopidogrel, azithromycin capsules, and povidone-iodine and ornidazole ointments also became cheaper. The goal is to make essential medicines more affordable.

Europe

Azithromycin prices were found to vary across the different countries in the European Union; however, the availability in some countries was a little worrisome. Union's Health Association's meeting discussed this in their annual meeting, where a coalition of a coalition Czechia, Cyprus, Malta, Romania, Slovakia, and Slovenia brought up the issue of excessive national stockpiling of medicines by some countries that could lead to significant shortages in other EU regions they highlighted that while securing medicine supplies is crucial, extreme stockpiling disrupts EU solidarity and the single market. Concerns focused on Germany's approach, which requires health insurers to maintain a six-month supply, a strategy also considered by Austria and France was raised. Overall, a mixed market dynamic was witnessed.

North America

In the second quarter of 2024, the price of azithromycin in the United States remained almost stable for most of the period. However, the overall inflation and the high cost of medications and healthcare remained a major subject of discussion especially as the election time approached in the States. The cost of prescription drugs is estimated to be propelled by more than 30% over the past decade. Some sluggishness in this cost growth has been observed over the past few months; however, the expensive healthcare still remains a big issue for the American people.

Analyst Insight

According to Procurement Resource, the Azithromycin prices are expected to remain oscillating within close limits in the coming months.
 

Azithromycin Price Trend for the Q1 of 2024

Stay updated with the latest Azithromycin prices, historical data, and tailored regional analysis
 

Asia

In India, azithromycin is one of the medicines listed on the National List of Essential Medicines (NLEM) since it is considered essential for addressing infectious diseases and is commonly prescribed by healthcare providers in India for various bacterial infections. The prices for these medicines are greatly regulated by the NPPA (National Pharmaceutical Pricing Authority) of India. Thus, the prices do not show much fluctuations despite the variations in upstream manufacturing and processing costs. The government wants these medicines to be readily available at cheaper prices for the low-earning population as well. So, the azithromycin prices remained almost stagnant during the given span of Q1’24.

NPPA has, however, announced a marginal increase of about 0.00551% to MRPs of NLEM drugs, including azithromycin, from April 2024. This minimal rise in prices, however, is not sitting right with the manufacturing firms as they are struggling with grappling increases in raw material costs, processing charges, and shipping rates. The revenue margins have been contracting consistently.

As various small and medium players in the drug market struggle to comply with the new, more strict rules of the health ministry regulations, many of them are expected to undergo closures. This will likely create a supply crunch in the medicine market. Troubled with this highly regulated essential medicine sector many big companies are shifting focus from essential medicines. The government is also reviewing the DPCO (Drug Price Control Order) to aid this market situation.

North America

In the USA, pharmaceutical companies have increased prices for over 700 medications at the start of the year, with an average increase of about 4.5%. Thus the azithromycin prices also experienced marginal rise in average prices. These increases are part of a trend where most brand prescription drug list price hikes occur in January or July each year.

The USA is considered one of the most expensive drug markets in the world. However, despite sticker price increases, net prices, which consider rebates and discounts, have been decreasing for about six years. The American Rescue Plan Act, passed in 2021, has led to record decreases in list prices for drugs like insulin and inhalers. These price hikes coincide with ongoing efforts in Washington, D.C., to address high drug costs, including medicare negotiation powers and limiting price increases to inflation rates.

Analyst Insight

According to Procurement Resource, the Azithromycin prices are likely to exude borderline stagnancy in the coming months as well. Not much change is anticipated in the drug prices moving forward.
 

Azithromycin Price Trend for the October - December of 2023

Asia

In order to counter the recent price hikes in the pharmaceutical sector and to curb the rising medical inflation in the country, the Indian government/ agencies are actively interviewing to increase affordability. Currently, the Supreme Court is addressing objections raised by the All India Drug Action Network on the drug pricing formula, citing concerns about super-profits, exclusion of critical medicines, and insufficient consultation.

Recently, the Indian National Pharmaceutical Pricing Authority (NPPA) has brought 33 fixed-dose combination drugs under regulation; manufacturers failing to comply with the price cap must reimburse overcharged amounts with interest. This step is all set to control the drug pricing, including Azithromycin prices, in the coming months.

North America

The pharmaceutical industry, including companies like Merck, Bristol-Myers Squibb, and Johnson & Johnson, is countering the US administration's drug price negotiation. The Inflation Reduction Act aims to lower drug costs and requires rebates if prices rise faster than inflation. Multiple lawsuits challenging the constitutionality of the program are in progress, with the industry arguing against unprecedented restrictions on drug prices.

Recently, companies, including Pfizer, Sanofi, and Takeda, plan to raise prices on over 500 drugs, including Azithromycin, starting January 2024 in order to counter the US Administration's publication of discounted prices for ten high-cost drugs. Further, the concerns about supply chain disruptions and rising costs of raw materials and manufacturing are also influencing the global pharmaceutical industry.

Analyst Insight

According to Procurement Resource, the Azithromycin price trend are likely to remain fluctuating in the coming quarter, given the current economic scenario and the pricing fundamentals. The ongoing disagreement between the US administration and the global pharmaceutical giants will greatly affect the global markets.
 

Azithromycin Price Trend for the July - September of 2023

Asia

Azithromycin is a potent antibiotic drug used for various purposes and symptoms in modern pharmaceuticals. Because of its widespread use, the demands from the consuming sectors are usually stable. During the third quarter, in line with the price forecasts, the Azithromycin prices inclined throughout.

The production costs were high because of inflation, and the disease season in India further escalated the azithromycin demand in the market. With these situations, the azithromycin prices rose consistently on the price graph. Overall, the Azithromycin market outlook was observed to be very positive throughout the said period.

Europe

The azithromycin situation in Europe was not much different from the Azithromycin market in Asia. Along with the consistent demands from the end user and consumer sectors, the growing transportation charges amidst weather disruptions also influenced the azithromycin price trend during the said period. Overall, positive market trend were observed.

North America

Following the other key global markets, the azithromycin prices in America also inclined throughout the said period. As the Chinese supplies were trying to cater to the domestic demand, the American imports struggled too, and thus, amidst a positive supply and demand dynamic, the prices grew consistently during the said period.

Analyst Insight

According to Procurement Resource, the Azithromycin price trend are likely to continue to rise in the coming months, given the stable market fundamentals.
 

Azithromycin Price Trend for the First Half of 2023

Asia

The azithromycin sector witnessed positive price growth in the first and second quarters of 2023. The rise was gradual in the first quarter but was steep in the second quarter. This upward trajectory in the prices of Azithromycin was supported by the decline in inventories and rising demand from the end-user sector.

Also, after a long period of stagnancy in China due to the lunar holiday season, the market regained its production potential. In the second quarter, the downstream industries raised their number of orders, and with rising inflation rates and soaring energy production prices, the trend of Azithromycin inclined significantly.

Europe

The market for Azithromycin was stagnant in the first quarter of 2023 as the purchasing potential of the pharmaceutical sector and the supply of the product in the region balanced each other. However, in the second quarter, the price trend inclined significantly. In Q2, the demand from the domestic and international players rose remarkably with the positive movement of the regional market. In addition, the ongoing Russia-Ukraine war caused the cost of energy production to rise, and as a result, the price trend of Azithromycin moved swiftly towards a positive trajectory.

North America

The price trend seen in the European region was also followed in North America. In the first quarter, the price trend increased gradually, supported by the consistent demand from the pharmaceutical sector and ease in trading activities.

In the second quarter, the rise in imports from China and increasing production activities of the downstream sector influenced the azithromycin market. In addition to this, the inflation in the region declined, and the energy cost surged, which further supported the azithromycin market.
 
Analyst Insight

According to Procurement Resource, the price of Azithromycin is expected to witness an inclining trajectory as the demand from the downstream industries and the cost of energy production are estimated to rise.

Procurement Resource provides latest prices of Azithromycin. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.